Bio-Techne Corporation Presents at Citi Annual Global Healthcare Conference 2025: CEO Discusses Q1 Results, Q2 Expectations, and Year-End Outlook.

Wednesday, Dec 3, 2025 6:46 pm ET1min read

Bio-Techne Corporation (TECH) presents at Citi Annual Global Healthcare Conference 2025. CFO James Hippel discusses Q1 results, which showed negative 1% growth due to 2 large cell therapy customers not purchasing material from the company. He expects Q2 to be similar and mentions changes in customer dynamics that affected the quarter.

Bio-Techne Corporation Presents at Citi Annual Global Healthcare Conference 2025: CEO Discusses Q1 Results, Q2 Expectations, and Year-End Outlook.

Comments



Add a public comment...
No comments

No comments yet